CDT Equity enters SAFE note investment in Pep'd with $10 million valuation cap

• CDT Equity entered into a SAFE with US-based peptide company Pep'd, positioning for minority equity exposure via automatic conversion at the next equity financing.
• SAFE converts into Safe Preferred Stock based on Pep'd capitalization at conversion, subject to a $10 million valuation cap.
• Transaction expands CDT’s exposure to the US peptide market, with plans to apply AI-enabled approaches to peptide development.
• Pep'd is controlled by CDT CEO Andrew Regan, who is also a director of CDT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608250500PRIMZONEFULLFEED9815503) on August 25, 2026, and is solely responsible for the information contained therein.